Search - tctmd.com

Displaying 141 - 160 of 173

Sort: Relevancy | Date

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

News Daily News

Early Invasive Treatment May Help Highest-Risk Women With NSTE ACS

Yael L. Maxwell

March 10, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Daily News

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

Caitlin E. Cox

March 05, 2025

Presentation CTO 2025

A Novel Non-Balloon-Based Coronary Intravascular Lithotripsy System: Device Overview, Early Experience and FORWARD CAD IDE Study Design

Presenter: Julian Strange

March 01, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2025

Shelley Wood

February 28, 2025

Presentation CTO 2025

Overview of the FORWARD CAD IDE Study

Presenter: Robert Yeh

February 28, 2025

News Daily News

ACC/AHA Release New Comprehensive ACS Guidelines

Todd Neale

February 27, 2025

News Daily News

Can’t Exercise for a Cardiac Stress Test? That’s a Bad Sign

Todd Neale

February 25, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Todd Neale

February 21, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

Presentation THT 2025

Regulatory Considerations for the Use of AI for Treating Patients With Heart Failure: The Intersection of Drugs and Devices

Presenter: Alex Cadotte

February 13, 2025

News Conference News STS 2025

Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis

Yael L. Maxwell

February 05, 2025

News Daily News

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Michael O'Riordan

February 05, 2025

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

Presentation Controversies and Advances 2025

The Guidelines are Wrong: Everyone with Severe Proximal or Mid Vessel CAD Should Have PCI Regardless of Symptoms

Presenter: Paul S. Teirstein

January 31, 2025

Presentation Controversies and Advances 2025

Antianginals or Stents are Reasonable Alternatives for Patients with Symptomatic CAD

Presenter: Rasha Al-Lamee

January 31, 2025

News Industry News

Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients

January 30, 2025

Advertisement

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Early Invasive Treatment May Help Highest-Risk Women With NSTE ACS

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

A Novel Non-Balloon-Based Coronary Intravascular Lithotripsy System: Device Overview, Early Experience and FORWARD CAD IDE Study Design

TCTMD’s Top 10 Most Popular Stories for February 2025

Overview of the FORWARD CAD IDE Study

ACC/AHA Release New Comprehensive ACS Guidelines

Can’t Exercise for a Cardiac Stress Test? That’s a Bad Sign

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Positive Results With Carillon Mitral Device Seen in Real-world Registries

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Regulatory Considerations for the Use of AI for Treating Patients With Heart Failure: The Intersection of Drugs and Devices

Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Use of Secondary CVD Prevention Meds Still Meager Worldwide

The Guidelines are Wrong: Everyone with Severe Proximal or Mid Vessel CAD Should Have PCI Regardless of Symptoms

Antianginals or Stents are Reasonable Alternatives for Patients with Symptomatic CAD

Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content